Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety, PK of AKT and MEK Combination
This study is currently recruiting participants.
Verified July 2012 by GlaxoSmithKline
Study NCT01138085   Information provided by GlaxoSmithKline

First Received on April 22, 2010.   Last Updated on November 21, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Cancer
Additional conditions recognized in this trial
Colorectal Neoplasms
Endometrial Neoplasms
Pancreatic Neoplasms
More general conditions related to this trial
Colonic Diseases
Digestive System Diseases
Digestive System Neoplasms
Endocrine Gland Neoplasms
Endocrine System Diseases
Gastrointestinal Diseases
Gastrointestinal Neoplasms
Genital Diseases, Female
Genital Neoplasms, Female
Intestinal Diseases
Intestinal Neoplasms
Neoplasms
Neoplasms by Site
Pancreatic Diseases
Rectal Diseases
Urogenital Neoplasms
Uterine Diseases
Uterine Neoplasms
Interventions listed in this trial
GSK1120212
GSK2141795
Sponsors listed in this trial
GlaxoSmithKline


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services